Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders

NCT02247427 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2014-09-25

No results posted yet for this study

Summary

The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.

Conditions

Interventions

DEVICE

Cardiac Resynchronization Therapy Device

Cardiac Resynchronization Therapy Device pacing activity, on or off

Sponsors & Collaborators

  • Yuksek Ihtisas Hospital

    lead OTHER

Principal Investigators

  • Serkan Cay, MD · Yuksek Ihtisas Hospital

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-06-30
Completion
2014-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247427 on ClinicalTrials.gov